Julian S. Gangolli

Insider Reports History

Location
Santa Ynez, CA
Signature
/s/Lawrence A. Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julian S. Gangolli:

Company Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Outlook Therapeutics, Inc. Director Stock Option (Right to Buy) 286,734 01 Oct 2025 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23,458 01 May 2024 Direct
Krystal Biotech, Inc. Director Stock Option (Right to Buy) 5,000 30 Jun 2025 Direct

Insider Reports Filed by Julian S. Gangolli

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 01 Oct 2025 1 $0 4 Director 03 Oct 2025, 19:45
KRYS Krystal Biotech, Inc. 30 Jun 2025 1 $0 4 Director 30 Jun 2025, 18:23
/report/000095017025015688-gangolli-julian-s-2025-02-04 Revance Therapeutics, Inc. 04 Feb 2025 2 -$109,887 4 Director 06 Feb 2025, 20:06
OTLK Outlook Therapeutics, Inc. 01 Oct 2024 2 $0 4 Director 03 Oct 2024, 21:22
KRYS Krystal Biotech, Inc. 30 Jun 2024 1 $0 4 Director 01 Jul 2024, 19:37
KRYS Krystal Biotech, Inc. 20 May 2024 5 -$2,827,690 4 Director 22 May 2024, 18:17
/report/000147929024000086-gangolli-julian-s-2024-05-01 Revance Therapeutics, Inc. 01 May 2024 2 $0 4 Director 03 May 2024, 08:44
OTLK Outlook Therapeutics, Inc. 07 Mar 2024 1 $0 4 Director 08 Mar 2024, 16:13
OTLK Outlook Therapeutics, Inc. 04 Oct 2023 1 $0 4 Director 06 Oct 2023, 08:16
KRYS Krystal Biotech, Inc. 30 Jun 2023 1 $0 4 Director 03 Jul 2023, 16:16
/report/000147929023000064-gangolli-julian-s-2023-05-03 Revance Therapeutics, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 17:15
OTLK Outlook Therapeutics, Inc. 29 Mar 2023 1 $0 4 Director 31 Mar 2023, 17:46
OTLK Outlook Therapeutics, Inc. 05 Oct 2022 1 $0 4 Director 07 Oct 2022, 16:36
KRYS Krystal Biotech, Inc. 30 Jun 2022 1 $0 4 Director 01 Jul 2022, 16:05
/report/000147929022000069-gangolli-julian-s-2022-05-04-restatement Revance Therapeutics, Inc. 04 May 2022 1 $0 4/A Director 13 May 2022, 18:14
OTLK Outlook Therapeutics, Inc. 23 Mar 2022 1 $0 4 Director 24 Mar 2022, 17:42
OTLK Outlook Therapeutics, Inc. 05 Oct 2021 1 $0 4 Director 07 Oct 2021, 17:07
KRYS Krystal Biotech, Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 11:33
/report/000147929021000108-gangolli-julian-s-2021-05-05 Revance Therapeutics, Inc. 05 May 2021 2 $0 4 Director 07 May 2021, 19:06